You are here

Article info

Article menu

Download PDFPDF

Review
Challenges and opportunities for checkpoint blockade in T-cell lymphoproliferative disorders

Authors

  • Tycel Phillips Department of Internal Medicine, Division of Hematology and OncologyUniversity of Michigan Ann Arbor MI USA PubMed articlesGoogle scholar articles
  • Sumana Devata Department of Internal Medicine, Division of Hematology and OncologyUniversity of Michigan Ann Arbor MI USA PubMed articlesGoogle scholar articles
  • Ryan A. Wilcox Department of Internal Medicine, Division of Hematology and OncologyUniversity of Michigan Ann Arbor MI USA University of Michigan Comprehensive Cancer Center 4310 Cancer Center, 1500 East Medical Center Drive 48109 Ann Arbor MI USA PubMed articlesGoogle scholar articles
  1. ↵a tycelp{at}umich.edu
  2. ↵b sdevata{at}umich.edu
  3. ↵c 734-615-9799 rywilcox{at}med.umich.edu
View Full Text

Citation

Phillips T, Devata S, Wilcox RA
Challenges and opportunities for checkpoint blockade in T-cell lymphoproliferative disorders
Journal for ImmunoTherapy of Cancer 2016;4:95. doi: 10.1186/s40425-016-0201-6

Publication history

  • Received August 22, 2016
  • Accepted December 1, 2016
  • First published December 20, 2016.
Online issue publication 
February 15, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.